Want to see TSE:EXE full AI Analyst Report?
EXE Stock Chart & Stats
C$29.10
-C$0.01(-0.10%)
At close: 4:00 PM EST
C$29.10
-C$0.01(-0.10%)
Day’s Range― - ―
52-Week RangeC$12.12 - C$39.14
Previous CloseN/A
Volume30.42K
Average Volume (3M)175.59K
Market Cap
C$3.55B
Enterprise ValueC$2.54K
Total Cash (Recent Filing)C$322.27M
Total Debt (Recent Filing)C$324.56M
Price to Earnings (P/E)27.0
Beta0.51
Next Earnings
Aug 06, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)1.38
Shares Outstanding95,046,400
10 Day Avg. Volume108,359
30 Day Avg. Volume175,588
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)4.88
Price to Sales (P/S)1.10
P/FCF Ratio28.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$39.20Price Target Upside34.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)1.53
Revenue Forecast (FY)C$2.25B
Bulls Say, Bears Say
Bulls Say
Improving Operating PerformanceSustained top-line growth and a meaningful EBITDA rebound indicate the company is regaining operational traction. Higher margins reflect better cost management and mix improvements, supporting more durable earnings generation over the next several quarters absent major funding shocks.
Stronger Balance SheetMaterial deleveraging and a larger equity base improve financial flexibility and credit resilience. Lower leverage reduces refinancing and interest-rate risk, enabling investment in operations or acquisitions and providing a buffer against industry cyclical pressures over the medium term.
Diversified Senior-care Revenue MixMultiple revenue streams—long-term care, home care, and services—reduce concentration risk and create cross-selling and contract growth opportunities. Home-care contracts and services can expand margins and offset LTC volatility, supporting steadier revenue over coming quarters.
Bears Say
Weak And Volatile Cash ConversionLow and falling FCF relative to earnings signals recurring working-capital/timing issues and limited cash conversion. This constrains reinvestment, dividend flexibility and debt paydown capacity, increasing vulnerability to cost shocks or funding changes over a multi-month horizon.
Modest Net MarginsMargins remain thin for a labor-intensive care provider, leaving limited cushion versus rising wage, occupancy or reimbursement pressures. Even modest adverse cost or funding shifts could materially compress profitability and free cash flow in the medium term.
Revenue Tied To Government Funding And ContractsHigh dependence on provincial reimbursement formulas and public contracts makes revenue and pricing sensitive to policy changes. Structural funding shifts or slower contract renewals would have a direct and lasting impact on revenues and margins over several quarters.
Extendicare News
EXE FAQ
What was Extendicare’s price range in the past 12 months?
Extendicare lowest stock price was C$12.12 and its highest was C$39.14 in the past 12 months.
What is Extendicare’s market cap?
Extendicare’s market cap is C$3.55B.
When is Extendicare’s upcoming earnings report date?
Extendicare’s upcoming earnings report date is Aug 06, 2026 which is in 13 days.
How were Extendicare’s earnings last quarter?
Extendicare released its earnings results on May 07, 2026. The company reported C$0.422 earnings per share for the quarter, beating the consensus estimate of C$0.21 by C$0.212.
Is Extendicare overvalued?
According to Wall Street analysts Extendicare’s price is currently Undervalued.
Does Extendicare pay dividends?
Extendicare pays a Monthly dividend of C$0.044 which represents an annual dividend yield of 1.38%. See more information on Extendicare dividends here
What is Extendicare’s EPS estimate?
Extendicare’s EPS estimate is 0.4.
How many shares outstanding does Extendicare have?
Extendicare has 95,046,400 shares outstanding.
What happened to Extendicare’s price movement after its last earnings report?
Extendicare reported an EPS of C$0.422 in its last earnings report, beating expectations of C$0.21. Following the earnings report the stock price went up 10.727%.
Which hedge fund is a major shareholder of Extendicare?
Currently, no hedge funds are holding shares in TSE:EXE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Extendicare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$39.20 (34.71% Upside)
C$39.20 (34.71% Upside)
Insider Transactions
Sold Shares
Worth C$65.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.1%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.69%
12-Months-Change
Fundamentals
Return on Equity
1.38%
Trailing 12-Months
Asset Growth
50.12%
Trailing 12-Months
Company Description
Extendicare
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Extendicare offers contract and consulting expertise to external entities. The organization oversees an extensive network consisting of 119 long-term care residences and retirement communities, alongside its dedicated home health care operations. These services are provided under prominent brand names such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. is headquartered in Markham, Canada.
EXE Stock 12 Month Forecast
Average Price Target
C$39.20
▲(34.71% Upside)